RecruitingPhase 3NCT03859921
Oral Dydrogesterone as Luteal Phase Support in Natural Cycle FET
A Randomized Double Blind Controlled Comparison of Oral Dydrogesterone as Luteal Phase Support in Natural Cycle Frozen-thawed Embryo Transfer
Sponsor
The University of Hong Kong
Enrollment
716 participants
Start Date
Jul 1, 2021
Study Type
INTERVENTIONAL
Conditions
Summary
This randomised double-blinded controlled trial aims to compare the live birth rate in natural FET cycles with and without oral dydrogesterone as luteal phase support. The hypothesis is that the use of oral dydrogesterone will increase the live birth rate of natural cycle FET.
Eligibility
Sex: FEMALEMin Age: 18 YearsMax Age: 42 Years
Inclusion Criteria2
- Age of women \<43 years at the time of stimulated IVF
- Replacing early cleavage embryos or blastocysts after thawing
Exclusion Criteria5
- Requiring hormonal replacement cycles
- Use of donor oocytes or embryos
- Undergoing preimplantation genetic testing
- Presence of hydrosalpinx not corrected surgically prior to FET
- Refusal to join the study
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGDydrogesterone
Progesterone
DRUGPlacebo
Placebo with appearance similar to Dydrogesterone
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03859921
Related Trials
A Novel Integrative Non-invasive Embryo Selection Approach for IVF Based on MK-RS Analysis
NCT058967091 location
GnRH Agonist for Dual Trigger in IVF and for Luteal Phase Support in FET
NCT040648401 location
Fertility and the Microbiome
NCT053289991 location
A Randomised Controlled Feasibility Trial of the Mechanisms of the Fertility Enhancing Effect of Lipiodol in Women
ACTRN126210011648861 location
The long-term impact of endometriosis on reproductive outcomes.
ACTRN126210004318209 locations